3-methylcholanthrene has been researched along with thiabendazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conran, P; Lovett, EJ; Lundy, J; Wolinsky, SM | 1 |
Delescluse, C; Ledirac, N; Lemaire, G; Lesca, P; Pralavorio, M; Rahmani, R | 1 |
2 other study(ies) available for 3-methylcholanthrene and thiabendazole
Article | Year |
---|---|
Immune impairment and metastatic tumor growth: the need for an immunorestorative drug as an adjunct to surgery.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Cytotoxicity, Immunologic; Female; Fibrosarcoma; Halothane; Immunity; Immunosuppression Therapy; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Sarcoma, Experimental; Thiabendazole | 1979 |
The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes.
Topics: Animals; Benz(a)Anthracenes; Benzoquinones; Cells, Cultured; Cytochrome P-450 CYP1A1; Enzyme Induction; Enzyme Inhibitors; Hepatocytes; Lactams, Macrocyclic; Male; Methylcholanthrene; Omeprazole; Polychlorinated Dibenzodioxins; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Rifabutin; RNA, Messenger; Thiabendazole | 2004 |